Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 15  |  Issue : 7  |  Page : 1635--1641

Antitumor activity of interleukin-18 on A549 human lung cancer cell line


Donglan Xiong1, Rui Feng2, Sheng Yang3, Tingyan Lin4, Xiangqi Chen4 
1 Department of Respiratory, Union Clinical Medical College of Fujian Medical University, Fujian, Fuzhou, China
2 Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, China
3 Department of Oncology, Fujian Medical University Union Hospital; Department of Oncology, Union Clinical Medical College of Fujian Medical University; Fujian Key Laboratory of Translational Cancer Medicine; Fujian Medical University Stem Cell Research Institute, Fujian, Fuzhou, China
4 Department of Respiratory, Union Clinical Medical College of Fujian Medical University, Fujian; 6Respiratory, Fujian Medical University Union Hospital, Fuzhou, China

Correspondence Address:
Prof. Xiangqi Chen
29 Xinquan Road, Fuzhou, Fujian 350001
China

Objective: In this study, we investigated the antitumor activity of interleukin (IL)-18 on A549 human lung cancer cell line and evaluated the potential of IL-18 therapy in lung cancer. Materials and Methods: We generated a human IL-18 lentiviral expression vector and examined three groups of A549 cells, including nontransduced cells and cells transduced with either IL-18 or an empty lentiviral expression vector. IL-18 expression, cell proliferation, and apoptosis were examined using Western blotting, methylthiazolyldiphenyl-tetrazolium bromide assay, and flow cytometry, respectively. The expression of the T helper 1 (Th1) cytokine interferon-γ (IFN-γ) and Th2 cytokine IL-4 was analyzed by enzyme-linked immunosorbent assay (ELISA). Results: Compared to the other groups of cells, A549 cells transduced with the IL-18 lentiviral expression vector exhibited significant increases in IL-18 expression, apoptosis, and the fraction of cells in G0 and G1 phases of the cell cycle and significant decrease in proliferation. Furthermore, ELISA results showed that IFN-γ expression increased significantly and IL-4 decreased in A549 cells transfected with IL-18 lentivirus expression vector. Conclusion: Using a lentiviral expression vector, IL-18 was expressed stably and efficiently in A549 cells, which showed attenuated proliferation and tumor cell growth, and enhanced tumor cell apoptosis. IL-18 expression also induced the secretion of IFN-γ, while decreasing the production of IL-4, therefore restoring the balance between Th1/Th2 cell subsets. These findings further demonstrated the antitumor activity of IL-18 and might open new therapeutic avenues for the prevention and treatment of lung cancer.


How to cite this article:
Xiong D, Feng R, Yang S, Lin T, Chen X. Antitumor activity of interleukin-18 on A549 human lung cancer cell line.J Can Res Ther 2019;15:1635-1641


How to cite this URL:
Xiong D, Feng R, Yang S, Lin T, Chen X. Antitumor activity of interleukin-18 on A549 human lung cancer cell line. J Can Res Ther [serial online] 2019 [cited 2020 Jun 5 ];15:1635-1641
Available from: http://www.cancerjournal.net/article.asp?issn=0973-1482;year=2019;volume=15;issue=7;spage=1635;epage=1641;aulast=Xiong;type=0